BioDelivery Sciences International, Inc.

Total Valuation

BioDelivery Sciences International, Inc. carries a market capitalization of 577.05M, placing it among publicly traded companies globally. Its enterprise value stands at 252.91M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

BioDelivery Sciences International, Inc. currently has 98.85M shares outstanding.

Valuation Ratios

BioDelivery Sciences International, Inc. trades at a trailing price-to-earnings ratio of 3.63. The price-to-sales ratio is 1.85, and the price-to-book ratio stands at -1.21.

Enterprise Valuation

On an enterprise value basis, BioDelivery Sciences International, Inc. trades at an EV/EBITDA multiple of 5.68 and an EV/FCF ratio of 4.02. The EV/Sales ratio of 1.52 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 6.81 provides insight into valuation relative to core operating earnings.

Financial Position

BioDelivery Sciences International, Inc. maintains a current ratio of 2.45, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 31.30, indicating elevated leverage, while an interest coverage ratio of 5.94 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, BioDelivery Sciences International, Inc. has paid -55.24M in income taxes, reflecting an effective tax rate of 15.72.

Stock Price Statistics

BioDelivery Sciences International, Inc.'s stock has gained approximately 0.53957015% over the past 52 weeks. The 50-day moving average sits at 4.96, while the 200-day moving average is 3.88.

Income Statement

Over the trailing twelve months, BioDelivery Sciences International, Inc. generated 166.71M in revenue and converted that into 84.86M in net income, yielding earnings per share of 0.82. EBITDA reached 44.55M, while operating income came in at 37.13M.

Balance Sheet

BioDelivery Sciences International, Inc. holds 114.31M in cash and equivalents against 58.79M in total debt, resulting in a net debt position of -55.52M. Total book value stands at -255.92M, with working capital of 119.69M providing operational flexibility.

Cash Flow

BioDelivery Sciences International, Inc. produced 41.04M in operating cash flow over the past twelve months. After subtracting -415,000.00 in capital expenditures, free cash flow totaled 40.62M - equivalent to 0.41 per share.

Margins

BioDelivery Sciences International, Inc. operates with a gross margin of 85.98, reflecting its pricing power and cost economics. The operating margin of 22.27 and net profit margin of 50.90 provide insight into operational efficiency.

Dividends & Yields

Scores

BioDelivery Sciences International, Inc. posts an Altman Z-Score of 1.64, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.